Stocchi, Fabrizio http://orcid.org/0000-0002-5763-0033
Antonini, Angelo http://orcid.org/0000-0003-1040-2807
Berg, Daniela
Bergmans, Bruno
Jost, Wolfgang http://orcid.org/0000-0002-8574-3297
Katzenschlager, Regina
Kulisevsky, Jaime http://orcid.org/0000-0003-4870-1431
Odin, Per
Valldeoriola, Francesc http://orcid.org/0000-0002-8680-4274
Ray Chaudhuri, K.
Article History
Received: 14 April 2021
Accepted: 22 December 2021
First Online: 21 February 2022
Competing interests
: Fabrizio Stocchi has received compensation for consultancy and speaker related activities from Zambon, UCB, Chiesi Pharma, Lundbeck, Sunovion, Bial, SynAgile, Biogen, Kiowa and Impax. Angelo Antonini has received compensation for consultancy and speaker related activities from UCB, Boehringer Ingelheim, General Electric, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Neuroderm, Theravance Biopharma, Roche, Medscape; he receives research support from Bial, Lundbeck, Roche, Angelini Pharmaceuticals, Horizon 2020 - Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation. He serves as consultant for Boehringer–Ingelheim for legal cases on pathological gambling. Daniela Berg reports grants from Janssen Pharmaceutica, grants from the Damp foundation, grants from the German Parkinson’s Disease Association (dPV), grants from BMWi, grants from BMBF, grants from the ParkinsonFonds Deutschland GmbH, grants and speaker’s honoraria from and consultancy honoraria of UCB Pharma GmbH, grants from and consultancies for Novartis Pharma GmbH, grants and speaker’s honoraria from and consultancy honoraria of Lundbeck, speaker’s honoraria from and consultancy honoraria of BIAL, speaker’s honoraria from and consultancy honoraria of Biogen, honoraria from Bayer and Zambon outside the submitted work. Bruno Bergmans has received grants and compensation for lectures and advisory functions from Abbvie, Zambon, Merz Pharma, Orion, Allergan and St Jude. Wolfgang Jost is advisor and speaker for Abbvie. Bial, Desitin, Stada, UCB, Zambon. Regina Katzenschlager has received honoraria for speaking and consulting from AbbVie, AOP Orphan, Bial, Britannia, Ever Pharma, Stada, UCB, and Zambon, and research grants from Britannia, Stada and Zambon within the past 3 years. Pier Odin has received compensation for lectures and advisory functions from AbbVie, Bial, Britannia, Ever Pharma, Lobsor, Nordic Infucare, Stada and Zambon. Jaime Kulisevsky: No conflicts regarding this manuscript. K. Ray Chaudhuri: Advisory board: AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Therevance, Scion, Britannia, Acadia, 4D. Honoraria for lectures: AbbVie, Britannia, UCB, Zambon, Novartis, Boeringer Ingelheim, Bial; Grants (Investigator Initiated): Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Academic grants: EU, IMI EU, Horizon 2020, Parkinson' UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.